Artificially grown organs or 3D bio printing of human skin, tissue, or internal organs may solve the problem. But the technology has long faced a roadblock. That is until now.
The new innovation may one day help patients in need like Marc Escalante.
For Escalante, his family means everything to him.
“I’ve got a lot of live for. I’ve got a wife, two children. My grandson, who will be graduating this year,” explained Escalante, who is in the security business.
Escalante inherited his mother’s beautiful smile. Unfortunately, he also inherited her chronic kidney disease. Marc is suffering from end-stage renal failure and needs dialysis. Both his kidneys are failing and he desperately needs an organ transplant.
“I need that kidney transplant it. I don’t want it. I need it.” said Escalante.
Unfortunately, the statistics are grim. As of February 2019, 120,000 people living in the United States were waiting for an organ transplant. Each day, dozens of people die in need of a transplant.
And many like Escalante — who has been on the waiting list so far for five years — will languish, waiting and wondering if he will ever get an organ.
“There are just not enough donors out there.” said Escalante.
But now a Bay Area Biotech company has taken a big step towards possibly resolving that shortage
“Our mission is to eliminate the transplant wait list,” said Melanie Matheu of Prellis Biologics.
Prellis Biologics intends to use 3D printers to build organs and tissues using a patient’s own cells.